We have previously shown that the overexpression of miR-193b reduces the proliferation of prostate cancer cells due to a decreased number of cells in S-phase of the cell cycle 8, suggesting that CCND1 could also be a target for miR-193b in prostate cancer. Here, CCND1 is linked to prostate carcinoma.